Bandhan BSE Healthcare Index Fund - Growth - Regular Plan

Other Plans and Options
  • 0.02 %Nav, as on 05-09-2025

  • Previous Nav

  • Net Change on 05-09-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the Scheme is to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Motilal Oswal Nifty Midcap 150 Index Fund - Regular Plan Sep 06, 2019 -3.69 20.75 26.16 1.00 2,472.47
Motilal Oswal Nifty 500 Index Fund - Regular Plan Sep 06, 2019 -3.73 14.37 19.35 0.88 2,432.38
DSP Nifty 50 Equal Weight Index Fund - Regular Plan - Growth Oct 23, 2017 -2.27 16.27 22.01 0.92 2,198.48
Axis Nifty 100 Index Fund - Regular Plan - Growth Option Oct 18, 2019 -3.22 12.36 17.25 0.92 1,917.61
Motilal Oswal Nifty Smallcap 250 Index - Regular Plan Sep 06, 2019 -8.35 21.13 27.14 1.04 969.97

Fund Holdings as on 31-July-2025

  • Sun Pharmaceutical Industries Limited

  • Max Healthcare Institute Limited

  • Cipla Limited

  • Divi's Laboratories Limited

  • Dr. Reddy's Laboratories Limited

  • Apollo Hospitals Enterprise Limited

  • Lupin Limited

  • Fortis Healthcare Limited

  • Torrent Pharmaceuticals Limited

  • Laurus Labs Limited

  • Glenmark Pharmaceuticals Limited

  • Aurobindo Pharma Limited

  • Mankind Pharma Limited

  • Alkem Laboratories Limited

  • Triparty Repo TRP_010825

  • Zydus Lifesciences Limited

  • Biocon Limited

  • IPCA Laboratories Limited

  • Cohance Lifesciences Limited

  • Krishna Institute Of Medical Sciences Limited

  • Abbott India Limited

  • Gland Pharma Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Wockhardt Limited

  • Aster DM Healthcare Limited

  • Syngene International Limited

  • Narayana Hrudayalaya Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Piramal Pharma Limited

  • Dr. Lal Path Labs Limited

  • Ajanta Pharma Limited

  • Neuland Laboratories Limited

  • Global Health Limited

  • Concord Biotech Limited

  • Jubilant Pharmova Limited

  • Natco Pharma Limited

  • Pfizer Limited

  • Rainbow Childrens Medicare Limited

  • Eris Lifesciences Limited

  • Poly Medicure Limited

  • Granules India Limited

  • Acutaas Chemicals Limited

  • AstraZeneca Pharma India Limited

  • Strides Pharma Science Limited

  • Alembic Pharmaceuticals Limited

  • Jupiter Life Line Hospitals Limited

  • Sai Life Sciences Limited

  • Sanofi India Limited

  • Vijaya Diagnostic Centre Limited

  • Metropolis Healthcare Limited

  • Shilpa Medicare Limited

  • Procter & Gamble Health Limited

  • Marksans Pharma Limited

  • Aarti Pharmalabs Limited

  • Sanofi Consumer Healthcare India Limited

  • Indegene Limited

  • Caplin Point Laboratories Limited

  • Emcure Pharmaceuticals Limited

  • Alivus Life Sciences Limited

  • Kovai Medical Center and Hospital Limited

  • Healthcare Global Enterprises Limited

  • Yatharth Hospital And Trauma Care Services Limited

  • FDC Limited

  • Indraprastha Medical Corporation Limited

  • Morepen Laboratories Limited

  • Thyrocare Technologies Limited

  • Sequent Scientific Limited

  • Solara Active Pharma Sciences Limited

  • Blue Jet Healthcare Ltd

  • Aarti Drugs Limited

  • Suven Life Sciences Limited

  • Supriya Lifescience Limited

  • Advanced Enzyme Technologies Limited

  • Dishman Carbogen Amcis Limited

  • Krsnaa Diagnostics Limited

  • Sun Pharma Advanced Research Company Limited

  • Innova Captab Limited

  • Akums Drugs and Pharmaceuticals Limited

  • Unichem Laboratories Limited

  • Gujarat Themis Biosyn Limited

  • Hikal Limited

  • IOL Chemicals and Pharmaceuticals Limited

  • Indoco Remedies Limited

  • Bliss GVS Pharma Limited

  • Orchid Pharma Limited

  • Gufic Biosciences Limited

  • RPG Life Sciences Limited

  • Vimta Labs Limited

  • Senores Pharmaceuticals Limited

  • Syncom Formulations India Limited

  • Windlas Biotech Limited

  • Hester Biosciences Limited

  • Artemis Medicare Services Limited

  • Sigachi Industries Limited

  • SMS Pharmaceuticals Limited

  • Novartis India Limited

  • Suraksha Diagnostic Limited

  • Shalby Limited

  • Tarsons Products Limited

  • Lincoln Pharmaceuticals Limited

  • GPT Healthcare Limited

  • Kopran Limited

  • Themis Medicare Limited

  • KMC Speciality Hospitals (India) Limited

  • Sastasundar Ventures Limited

  • NGL Fine Chem Limited

  • Cash Margin - CCIL

  • Net Current Assets

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Medical Equipment/Supplies/Accessories

  • Chemicals

  • Trading

  • Plastic Products

  • Finance - NBFC

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About Bandhan BSE Healthcare Index Fund

Scheme Analysis

Bandhan BSE Healthcare Index Fund is a Index Funds - Other fund and belongs to Bandhan Mutual Fund. It was launched on 06-Sep-2024 and currently has an AUM of ₹18.76 crore. Bandhan BSE Healthcare Index Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Bandhan BSE Healthcare Index Fund ended up ₹0(0.02%)yesterday to ₹10.1264.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Bandhan BSE Healthcare Index Fund is managed by Abhishek Jain .

Fund House Contact

6th Floor, One World Centre, 841, Jupiter Mills Compound, Senapati Bapat Marg, Elphinstone Road (West), Mumbai - 400 013

022-66289999
022-24215052